Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
03/24/2015 03/25/2015 03/26/2015 03/27/2015 03/30/2015 Date
8.8 8.74 8.74 8.5 8.6 Last
457 1300 1358 376 100 Volume
-1.12% -0.68% 0.00% -2.75% +1.18% Change
Financials ( CAD)
Sales 2015 0,83 M
EBIT 2015 -51,2 M
Net income 2015 -33,1 M
Debt 2015 -
Yield 2015 -
Sales 2016 1,67 M
EBIT 2016 -25,5 M
Net income 2016 -14,2 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 364x
Capi. / Sales 2016 182x
Capitalization 304 M
More Financials
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets.It operates through research and development of therapeutic agents segment.The company's products include ELND005 for the treatment of alzheimer's... 
Sector
Pharmaceuticals
Calendar
05/12Earnings Release
More about the company
Latest news on TRANSITION THERAPEUTICS IN
03/26 TRANSITION THERAPEUTICS : Announces Results from Phase 1 AME & Renal Clearance C..
03/02 TRANSITION THERAPEUTICS : Announces Enrolment Completion of ELND005 Phase 2 Clin..
02/24 TRANSITION THERAPEUTICS INC : LifeSci Capital Initiates Coverage of Transition T..
02/19 TRANSITION THERAPEUTICS : to Present at the Cowen and Company 35th Annual Health..
02/18 TRANSITION THERAPEUTICS : Announces Closing of Public Offering of US$23 Million ..
02/12 TRANSITION THERAPEUTICS : Announces Pricing of Public Offering of US$20 Million ..
02/11 TRANSITION THERAPEUTICS : Announces Public Offering of Common Shares
02/09 TRANSITION THERAPEUTICS : Announces Second Quarter Fiscal 2015 Financial Results
More news
Sector news : Biopharmaceuticals
03/31 ASTELLAS PHARMA : Celebrates 10th Anniversary
03/31 Neurocrine,Mitsubishi Tanabe To Develop &Commercialize VMAT2 Inhibitor NBI-98..
03/31 MYLAN NV : N.V. : Announces Pricing of Secondary Public Offering of a Portion of..
More sector news : Biopharmaceuticals
News from SeekingAlpha
02/11 Transition Therapeutics initiates equity offering
02/09 Transition Therapeutics' (TTHI) CEO Tony Cruz on Q2 2015 Results - Earnings C..
02/09 Transition Therapeutics reports FQ2 earnings


Comments 
Advertisement
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF